And these experiments may create new IP, eventually new patents being granted with Patrys seizing on long term exclusivity.
The amount that Pfizer has just paid for the leader in ADC speaks clear on the future of this therapeutic class.
Another little duck aligned today and with that it is now reasonable to assume that discussion are progressing towards an initial deal.
It may take a month or less, or more (?) but the probabilities for a deal to be sealed next Quarter have now swung for the affirmative.
And these experiments may create new IP, eventually new patents...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $16.52K | 5.509M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 58473651 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 10774833 | 14 |
View Market Depth
| Last trade - 11.22am 07/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |